Department of Error (DOI:10.1016/S0140-6736(06)67970-1);Antivirals for influenza in healthy adults: Systematic review

Lancet

Volumn 367, Issue 9507, 2006, Pages 303-313

  Jefferson, T ^a   Demicheli, V ^a   Rivetti, D ^a   Jones, M ^b   Di Pietrantonj, C ^a   Rivetti, A ^a  

^a ASL 20   (Italy)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ARTICLE; CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; HALLUCINATION; HUMAN; INFLUENZA VIRUS A; INSOMNIA; META ANALYSIS; NAUSEA; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 31444436460     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68926-5     Document Type: Erratum

References (71)

1. F Aoki Amantadine and rimantadine KG Nicholson RG Webster AJ Hay Textbook of influenza 1998 Blackwell Science Oxford 457 476
2. P Ward, I Small, J Smith, P Suter, R Durkowski Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic J Antimicrob Chem 55 suppl 1 2005 i15 i21
3. WHO Global agenda on influenza surveillance and control http://www.who.int/csr/disease/influenza/csrinfluenzaglobalagenda/en/print.html (accessed Oct 10, 2005)
4. European Medicines Agency Summary report: review on influenza antiviral medicinal products for potential use during pandemic (EMEA/CHMP/339972/2005) 2005 European Medicines Agency London
5. D Turner, A Wailoo, K Nicholson Systematic review and economic decision modelling for the prevention and treatment of influenza A and B Health Technol Assess 7 2003 1 170
6. A Burls, W Clark, T Stewart Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation Health Technol Assess 6 2002 1 87
7. NJ Cooper, AJ Sutton, KR Abrams Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analysis of randomised controlled trials BMJ 326 2003 1235 1240
8. T Jefferson, JJ Deeks, V Demicheli, D Rivetti, M Rudin Amantadine and rimantadine for preventing and treating influenza A in adults Cochrane Database Syst Rev 3 2004 CD001169
9. T Jefferson, V Demicheli, J Deeks, D Rivetti Neuraminidase inhibitors for preventing and treating influenza in healthy adults Cochrane Database Syst Rev 2 1999 CD001265
10. JJ Deeks, JPT Higgins, DG Altman Analysing and presenting results P Alderson S Green J Higgins Cochrane reviewer's handbook 4.2.2 (updated March, 2004). In: The Cochrane Library, Issue 1, 2004 2004 John Wiley & Sons Chichester
11. JP Higgins, SG Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
12. M Parmar, V Torri, L Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834
13. R Hurlburt Comprehending behavioral statistics 1994 Brooks/Cole Pacific Grove
14. MT Brady, SD Sears, DL Pacini Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic Antimicrob Agents Chemother 34 1990 1633 1636
15. E Callmander, L Hellgren Amantadine hydrochloride as a prophylactic in respiratory infections: a double-blind investigation of its clinical use and serology J Clin Pharmacol J New Drugs 8 1968 186 189
16. R Dolin, RC Reichman, HP Madore, R Maynard, PN Linton, J Webber-Jones A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection N Engl J Med 307 1982 580 584
17. AW Galbraith, JS Oxford, GC Schild, CW Potter, GI Watson Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A 2 -Hong Kong infection: a controlled double-blind study Lancet 2 1971 113 115
18. FG Hayden, JM Gwaltney Jr, RL Van de Castle, KF Adams, B Giordani Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults Antimicrob Agents Chemother 19 1981 226 233
19. FG Hayden, WJ Hall, RG Douglas Jr Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus J Infect Dis 141 1980 535 542
20. FG Hayden, AS Monto Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults Antimicrob Agents Chemother 29 1986 339 341
21. RB Hornick, Y Togo, S Mahler, D Iezzoni Evaluation of amantadine hydrochloride in the treatment of A2 influenzal disease Bull World Health Organ 41 1969 671 676
22. S Ito, N Iijima, K Kanemaki Therapeutic efficacy of amantadine hydrochloride in patients with epidemic influenza A virus infection Nihon Kokyuki Gakkai Zasshi 38 2000 897 902
23. RJ Kantor, DW Potts, D Stevens, GR Noble Prevention of influenza A/USSR/77 (H1N1): an evaluation of the side effects and efficacy of amantadine in recruits at Fort Sam Houston Mil Med 145 1980 312 315
24. O Kitamoto Therapeutic effectiveness of amantadine hydrochloride in influenza A2 - double blind studies Jpn J Tuberc Chest Dis 15 1968 17 26
25. O Kitamoto Therapeutic effectiveness of amantadine hydrochloride in naturally occurring Hong Kong influenza: double-blind studies Jpn J Tuberc Chest Dis 17 1971 1 7
26. V Knight, D Fedson, J Baldini, RG Douglas, RB Couch Amantadine therapy of epidemic influenza A2 (Hong Kong) Infect Immun 1 1970 200 204
27. J Mate, M Simon, I Juvancz, G Takatsy, I Hollos, E Farkas Prophylactic use of amantadine during Hong Kong influenza epidemic Acta Microbiol Acad Sci Hung 17 1970 285 296
28. VM Millet, M Dreisbach, YJ Bryson Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine Antimicrob Agents Chemother 21 1982 1 4
29. AS Monto, RA Gunn, MG Bandyk, CL King Prevention of Russian influenza by amantadine JAMA 241 1979 1003 1007
30. RL Muldoon, ED Stanley, GG Jackson Use and withdrawal of amantadine chemoprophylaxis during epidemic influenza A Am Rev Respir Dis 113 1976 487 491
31. I Nafta, AG Turcanu, I Braun Administration of amantadine for the prevention of Hong Kong influenza Bull World Health Organ 42 1970 423 427
32. N Oker-Blom, T Hovi, P Leinikki, T Palosuo, R Pettersson, J Suni Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trial BMJ 3 1970 676 678
33. DK Payler, PA Purdham Influenza A prophylaxis with amantadine in a boarding school Lancet 1 1984 502 504
34. RO Peckinpaugh, FB Askin, WE Pierce, EA Edwards, DP Johnson, GG Jackson Field studies with amantadine: acceptability and protection Ann N Y Acad Sci 173 1970 62 73
35. RF Pettersson, PE Hellstrom, K Penttinen Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: a controlled field trial among young adults and high-risk patients J Infect Dis 142 1980 377 383
36. V Plesnik, F Heinz, B Bindas Controlled study of influenza prophylaxis by VUFB amantadin Cesk Epidemiol Mikrobiol Imunol 26 1977 216 226
37. JM Quarles, RB Couch, TR Cate, CB Goswick Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza Antiviral Res 1 1981 149 155
38. S Rabinovich, JT Baldini, R Bannister Treatment of influenza: the therapeutic efficacy of rimantadine HC1 in a naturally occurring influenza A2 outbreak Am J Med Sci 257 1969 328 335
39. PD Reuman, DI Bernstein, MC Keefer, EC Young, JR Sherwood, GM Schiff Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A Antiviral Res 11 1989 27 40
40. M Schapira, JS Oxford, AW Galbraith A study of 1-adamantamine hydrochloride during the 1970 Hong Kong influenza epidemic J R Coll Gen Pract 21 1971 695 697
41. AA Smorodintsev, GI Karpuhin, DM Zlydnikov The prophylactic effectiveness of amantadine hydrochloride in an epidemic of Hong Kong influenza in Leningrad in 1969 Bull World Health Organ 42 1970 865 872
42. LP Van Voris, RF Betts, FG Hayden, WA Christmas, RG Douglas Jr Successful treatment of naturally occurring influenza A/USSR/77 H1N1 JAMA 245 1981 1128 1131
43. HA Wendel, MT Snyder, S Pell Trial of amantadine in epidemic influenza Clin Pharmacol Ther 7 1966 38 43
44. WL Wingfield, D Pollack, RR Grunert Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man N Engl J Med 281 1969 579 584
45. SW Younkin, RF Betts, FK Roth, RG Douglas Jr Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine Antimicrob Agents Chemother 23 1983 577 582
46. FY Aoki, DM Fleming, AD Griffin, LA Lacey, S Edmundson Impact of zanamivir treatment on productivity, health status and healthcare resource use in patients with influenza: Zanamivir Study Group Pharmacoeconomics 17 2000 187 195
47. G Boivin, N Goyette, I Hardy, F Aoki, A Wagner, S Trottier Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults J Infect Dis 181 2000 1471 1474
48. FG Hayden, RL Atmar, M Schilling Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza N Engl J Med 341 1999 1336 1343
49. FG Hayden, R Belshe, C Villanueva Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis J Infect Dis 189 2004 440 449
50. FG Hayden, AD Osterhaus, JJ Treanor Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections: GG167 Influenza Study Group N Engl J Med 337 1997 874 880
51. L Kaiser, D Henry, NP Flack, O Keene, FG Hayden Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study Clin Infect Dis 30 2000 587 589
52. L Kaiser, C Wat, T Mills, P Mahoney, P Ward, F Hayden Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations Arch Intern Med 163 2003 1667 1672
53. S Kashiwagi, S Kudoh, A Watanabe, I Yoshimura Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza: placebo-controlled double-blind multicenter phase III trial Kansenshogaku Zasshi 74 2000 1062 1076
54. S Kashiwagi, S Kudoh, A Watanabe, I Yoshimura Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza: placebo-controlled double-blind multicenter phase III trial Kansenshogaku Zasshi 74 2000 1044 1061
55. L Li, B Cai, M Wang, Y Zhu A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China Chin Med J (Engl) 116 2003 44 48
56. MJ Makela, K Pauksens, T Rostila Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study J Infect 40 2000 42 48
57. K Matsumoto, N Ogawa, K Nerome Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan - GG167 Group Antivir Ther 4 1999 61 68
58. AS Monto, DP Robinson, ML Herlocher, JM Hinson Jr, MJ Elliott, A Crisp Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial JAMA 282 1999 31 35
59. AS Monto, DM Fleming, D Henry Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections J Infect Dis 180 1999 254 261
60. KG Nicholson, FY Aoki, AD Osterhaus Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial: Neuraminidase Inhibitor Flu Treatment Investigator Group Lancet 355 2000 1845 1850
61. T Puhakka, H Lehti, R Vainionpaa Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza Scand J Infect Dis 35 2003 52 58
62. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections Lancet 352 1998 1877 1881
63. JJ Treanor, FG Hayden, PS Vrooman Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial: US Oral Neuraminidase Study Group JAMA 283 2000 1016 1024
64. R Welliver, AS Monto, O Carewicz Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial JAMA 285 2001 748 754
65. KY Yuen, SSY Wong Human infection by avian influenza A H5N1 Hong Kong Med J 3 2005 189 199
66. The writing committee of the World Health Organization (WHO) consultation on human influenza H5N1 Avian influenza A (H5N1) infection in humans N Engl J Med 353 2005 1374 1385
67. M Koopmans, B Wilbrink, M Conyn Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands Lancet 363 2004 587 593
68. SA Tweed, DM Skowronski, ST David Human illness from avian influenza H7N3, British Columbia Emerg Infect Dis 10 2004 2196 2199
69. RA Bright, M-J Medina, X Xu Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern Lancet 366 2005 1175 1181
70. M Kiso, M Mitamura, Y Sakai-Tagawa Resistant influenza A viruses in children treated with oseltamivir: descriptive study Lancet 364 2004 759 765
71. MD De Jong, TT Thanh, TH Khanh Oseltemivir resistance during treatment of influenza (H5N1) infection N Engl J Med 353 2005 2667 2672